Aurora Cannabis (ACB, Financial) experienced a significant stock price increase of 5.00%, reaching $4.31 per share with a trading volume of 372,159 shares and a turnover rate of 0.68%. The stock's volatility was recorded at 7.02%. Recent financial reports show revenues of $59.47 million, a net profit of $1.91 million, and an earnings per share of -$0.16. The gross profit stood at $586,521.99, with a price-to-earnings ratio of -6.60.
In analyst ratings, 33% of the six participating institutions recommend buying, while 67% suggest holding. Within the pharmaceutical industry, Aurora Cannabis saw an overall sector increase of 1.20%. Other notable movers include Ironwood Pharmaceuticals and Bioage Labs, Inc. Aurora Cannabis, headquartered in Edmonton, Canada, focuses on the cultivation and sale of medical and recreational cannabis under various brands. The company has expanded internationally through agreements in over 20 countries.
